Jaguar Health, Inc. (JAGX) is a publicly traded Healthcare sector company. As of July 14, 2026, JAGX trades at $2.24 with a market cap of $10.93M and a P/E ratio of -0.07. JAGX moved -3.56% today. Year to date, JAGX is -92.68%; over the trailing twelve months it is -97.15%. Its 52-week range spans $2.12 to $1,057.95. Rallies surfaces JAGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for JAGX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.24 |
| Market Cap | $10.93M |
| P/E Ratio | -0.07 |
| EPS | $-30.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,057.95 |
| 52-Week Low | $2.12 |
| Volume | 10.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $29.57M |
| Net Income | $-34.68M |
| Gross Margin | 85.06% |
JAGX analyst coverage data. Average price target: $0.00.